Nutraceuticals for the Management of Cardiovascular Health: A Mechanistic and Evidence-Based Review Focusing on Atherosclerosis and Hypertension.
P, A., C, G.A., NSN, C., L, G., KK, K., S, S., KVK, D., & N, U. (2026). Nutraceuticals for the Management of Cardiovascular Health: A Mechanistic and Evidence-Based Review Focusing on Atherosclerosis and Hypertension.. Nutrients. https://doi.org/10.3390/nu18142226
P A, C GA, NSN C, L G, KK K, S S, et al. Nutraceuticals for the Management of Cardiovascular Health: A Mechanistic and Evidence-Based Review Focusing on Atherosclerosis and Hypertension.. Nutrients. 2026; doi: 10.3390/nu18142226
P A, C GA, NSN C, et al. Nutraceuticals for the Management of Cardiovascular Health: A Mechanistic and Evidence-Based Review Focusing on Atherosclerosis and Hypertension.[J]. Nutrients. 2026. DOI: 10.3390/nu18142226.
@article{p2026,
author = {Alugoju P and Goud Alladi C and Chaitanya NSN and Goenka L and Kumaree KK and Sj S and Duraisamy KVK and Ullah N},
title = {Nutraceuticals for the Management of Cardiovascular Health: A Mechanistic and Evidence-Based Review Focusing on Atherosclerosis and Hypertension.},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18142226},
note = {PMID: 42514295},
}
TY - JOUR AU - Alugoju P AU - Goud Alladi C AU - Chaitanya NSN AU - Goenka L AU - Kumaree KK AU - Sj S AU - Duraisamy KVK AU - Ullah N TI - Nutraceuticals for the Management of Cardiovascular Health: A Mechanistic and Evidence-Based Review Focusing on Atherosclerosis and Hypertension. T2 - Nutrients PY - 2026 DO - 10.3390/nu18142226 AN - PMID:42514295 ER -
Cardiovascular diseases (CVDs) constitute one of the leading global health burdens, accounting for nearly 50% of all deaths worldwide. Rapid urbanization, lifestyle transitions, psychosocial stress, socioeconomic factors, and changing dietary patterns significantly influence cardiovascular health. Among modifiable risk determinants, atherosclerosis (AS) and hypertension (HTN) are the most critical, interrelated contributors to the onset and progression of CVDs. Nutritional interventions have gained significant global recognition in public health science and clinical practice and are widely regarded as a preventive approach for effective disease management. The goal of the current review is to present evidence from research conducted over the past decade (from 2016 to 2025) supporting the role of nutraceuticals in the management of AS and HTN. This review thoroughly discusses the role of nutraceuticals derived from diverse sources (plants, animals, microorganisms, etc.) from mechanistic aspects to clinical trial endpoints.